Free shipping on orders ₱1,000 and aboveFree shipping on orders ₱1,000 and above | Nationwide delivery

Fenofibrate 160mg Capsule — FENOCRON — 160mg | Dr. Med Pharmacy

Prescription MedicinesPrescription required

FENOCRON

Fenofibrate 160mg Capsule

SKU #: DMP-MD-120

Fenofibrate 160mg Capsule is an antihyperlipidemic medicine belonging to the fibrate class. It helps lower triglyceride levels and can also improve other blood lipid levels by activating peroxisome proliferator-activated receptor alpha (PPARα), which increases the breakdown and removal of triglyceride-rich lipoproteins.

FDA Registration Number: DRP-16092

Low stock: only 1 left!

₱1,800.00₱1,260.0030% OFF

VAT-exempt

Pack size: 100 Capsules

Prescription required: Prescription medicines require a valid prescription and pharmacist approval before dispensing. Do not use this site to obtain medicines without appropriate medical supervision.

Dr. Med Pharmacy Quality Promise

Authentic medicines, pharmacist-backed service, and transparent product information.

Product details

Generic Name:Fenofibrate

Category:Prescription Medicines

Brand:FENOCRON

Strength:160mg

Dosage Form:Capsule

Indications

Used as an adjunct to diet for the treatment of hypercholesterolemia and mixed dyslipidemia, and for adult patients with hypertriglyceridemia. It may also be used for persistent secondary hyperlipoproteinemia after appropriate treatment of the underlying condition.

Contraindications

Hypersensitivity or allergy to fenofibrate or any component of the formulation.
Severe renal impairment, including patients receiving dialysis.
Active liver disease, hepatic dysfunction, primary biliary cirrhosis, or unexplained persistent liver function abnormalities.
Pre-existing gallbladder disease.
Known photoallergic or phototoxic reaction during treatment with fenofibrate or ketoprofen.
Chronic or acute pancreatitis, except acute pancreatitis caused by severe hypertriglyceridemia.
Pregnancy.
Breastfeeding.
Use in children.

Warnings and Precautions

Appropriate diet, exercise, weight management, and treatment of secondary causes of abnormal lipid levels should be addressed before and during fenofibrate therapy.
Liver function should be assessed before treatment and monitored periodically. Fenofibrate should be discontinued if significant or persistent liver abnormalities develop.
Fenofibrate may cause myopathy and, rarely, rhabdomyolysis. Seek medical attention for unexplained muscle pain, tenderness, cramps, or weakness, particularly if accompanied by fever or malaise.
The risk of muscle toxicity is increased in patients with renal impairment, hypothyroidism, advanced age, or when fenofibrate is used together with statins or certain other lipid-lowering medicines.
Kidney function should be monitored, particularly in patients with renal impairment, diabetes, older adults, or those at increased risk of renal dysfunction.
Fenofibrate may increase the risk of gallstones. Medical assessment is required if symptoms suggestive of gallbladder disease occur.
Pancreatitis has been reported during fenofibrate therapy. Seek medical attention for severe or persistent abdominal pain.
Fenofibrate may increase the effect of anticoagulants and increase bleeding risk. Patients taking anticoagulant medicines may require closer monitoring.
Serious hypersensitivity and severe skin reactions may occur. Stop treatment and seek immediate medical attention if facial swelling, difficulty breathing, severe rash, blistering, or mucosal lesions develop.
Treatment should be continued together with the prescribed lipid-lowering diet and monitored periodically to assess response.

Fenofibrate 160mg Capsule

Product details

Indications

Contraindications

Warnings and Precautions

Related products

Acetylcysteine 200mg Powder For Oral Solution

Acetylcysteine 200mg Powder For Oral Suspension

Amlodipine (as Besilate) 5mg Tablet

Amlodipine Besilate 10mg Tablet